Schedule 13G ownership disclosure
INTERCEPT PHARMACEUTICALS IN
Security class unavailable · CUSIP: 45845P108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,019,983
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000739
- Form type
- SC 13G
- Filer
- INTERCEPT PHARMACEUTICALS, INC.
- CIK
- CIK 1270073
- Filed
- Oct 12, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership